.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma fold, occupying the top science area at Sanofi.Quigley will certainly begin Sept. 30 as the French Big Pharma’s main clinical police officer and also worldwide head of study, Sanofi informed Brutal Biotech in an emailed declaration.Quigley is switching out Frank Nestle, M.D., who left Sanofi this spring surrounded by a global overhaul of the company’s R&D unit. Nestle, who spent eight years along with the pharma, leapt over to Deerfield Administration, where he currently works as a companion on the therapeutics crew and CEO of the organization’s restorative discovery and also advancement procedures.
Quigley is going to sign up with Sanofi from a San Francisco-based biotech that’s in stealth, according to his LinkedIn profile page. He’s presently listed as the provider’s founder, head of state and also chief executive officer.Given that August 2021, Quigley has actually functioned as a project partner at SV Health Investors, a medical care fund manager along with current assets in biotechs such as BioAge, Cerevance, Dualitas Therapies and also Nimbus Rehabs, and many more. Quigley formerly held the leading location at Dualitas, a biotech that stays in secrecy, depending on to STAT.The future Sanofi leader also previously helmed Therini Bio, an immunotherapy biotech working to create treatments for neurodegenerative diseases steered by general disorder.Prior to devoting the final handful of years in biotech, Quigley possesses an also longer track record in Major Pharma, very most just recently acting as Gilead’s senior vice head of state of study biology till the summer months of 2021.
Before that, he clocked in much more than 4 years throughout a variety of management duties at Bristol Myers Squibb and also acted as a clinical director at Johnson & Johnson’s Janssen arm before that.Sanofi pointed out Quigley’s goal in his new function will be to “maximize our possibility of excellence with optimum collaborations all over our association and also past, taking best-in-class advancement as well as building and also sourcing brand new industry-leading skill with a commitment to range,” depending on to an inner memorandum acquired through STAT.